INTRODUCTION
Spectrin is the major structural component of the erythrocyte membrane skeleton that maintains cellular shape, regulates the lateral mobility of integral membrane proteins, and provides structural support for the lipid bilayer. 1 It is composed of 2 subunits, α and β spectrin, encoded by separate genes. 1, 2 Throughout erythropoiesis, there are significant changes in the synthesis, expression, and membrane assembly of spectrin. Early in erythropoiesis, α spectrin is synthesized in great excess, 3, 4 a process controlled at the transcriptional level. 3, 5, 6 The molecular mechanisms that regulate the erythroid tissue-specific and developmental stage-specific expression of α-spectrin, including the mechanisms that control the increase in α-spectrin gene transcription to high levels during the early stages of erythropoiesis, are unknown.
In the mature erythrocyte, quantitative and qualitative disorders of α spectrin have been associated with inherited hemolytic anemias, including hereditary spherocytosis (HSp), hereditary elliptocytosis (HE), and hereditary pyropoikilocytosis (HPP). [7] [8] [9] [10] [11] [12] In most recessive
HSp and many HPP patients, there is a defect in α-spectrin mRNA accumulation associated with spectrin deficiency. 7, 13, 14 With a few rare exceptions, the cause of the defect in α-spectrin expression in erythrocytes of these patients is unknown, even after nucleotide sequence analysis of the exons corresponding to the α-spectrin coding region and the minimal promoter region. 15, 16 Our previous studies demonstrated that a minimal α-spectrin promoter directed low levels of expression only in the early stages of erythroid development, indicating elements outside the promoter are required for expression in adult erythroid cells. 17 Additional studies identified a 183bp region 3' of the α-spectrin gene promoter composed of non-coding exon 1'
and intron 1' of the α-spectrin gene directed expression in reporter gene/transfection assays.
18
Both exon 1' and intron 1' in their proper genomic orientation relative to the α-spectrin minimal only.
For personal use at PENN STATE UNIVERSITY on February 23, 2013 . bloodjournal.hematologylibrary.org From promoter were required for full activity in reporter gene assays, in part due to GATA-1-dependent positive expression directed by intron 1'. The chromatin in this 183bp region contains a DNase I hypersensitive site and exhibits hyperacetylation of histones H3 and H4.
We hypothesize that both cis sequences and trans factors modulate chromatin structure and control α-spectrin gene regulation. Identifying these elements will provide important insights into the role of α-spectrin synthesis in early erythropoiesis, the pathogenesis of decreased α-spectrin expression in spectrin-deficient patients with inherited hemolytic anemia, and may provide a tool to direct high-level, tissue-specific expression of other erythroid-specific genes in gene transfer applications. To address this hypothesis in vivo, we examined the 183bp exon 1' and intron 1' region of the α-spectrin gene fragment in a transgenic mouse assay. When added to the minimal α-spectrin promoter, the region directed expression of a linked 19, 20 These data identify the first barrier element described in an erythrocyte membrane protein gene and indicate this is an excellent candidate region for mutations in patients with spectrin-linked hemolytic anemia.
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For personal use at PENN STATE UNIVERSITY on February 23, 2013. bloodjournal.hematologylibrary.org From Generation of transgenic mice. Transgenic mice were generated as described by Hogan et al. 21, 22 Founder animals were identified by Southern blot analysis of DNA extracted from tail biopsies by probing with α-spectrin/ A γ-globin probe. Founder animals were crossed to FVB/N mice for propagation. Copy number determination and statistical analyses were performed as described. 21, 23 The Animal Care and Use Committees of Yale University and the National Institute of Health have approved the animal studies described in this report. Detection and measurement of γ-globin protein in erythrocytes was performed as described by Thorpe et al. 24 Insulator assays. Barrier element activity was analyzed in a gene silencing/positioneffect assay. 25, 26 Test plasmids containing the enhanced green fluorescent protein (EGFP) as reporter gene was co-transfected into K562 cells with a pRSV-neomycin plasmid. After selection, individual clones were isolated and expanded in G418-containing medium and switched to non-selective medium before analysis of GFP expression via fluorescent-activated cell sorting. Southern blot analysis was used to confirm selected clones had an intact GFP construct. The negative control plasmid, HS2-β-GFP, consisted of the mouse β-globin HS2 enhancer, the human β-globin gene promoter, and the EGFP reporter gene. The positive control plasmid consisted of the HS2-β-GFP cassette flanked with hypersensitive site 4 from the chicken β-globin cluster locus control region (cHS4) insulator element.
Materials and Methods

Preparation of α-spectrin
Enhancer blocking activity was analyzed in a well-defined assay where elements under study are assessed for their ability to act as an enhancer blocker when placed between an enhancer and a promoter. 27 α-Spectrin sequences were used to separate the mouse β-globin HS2 enhancer 28 from a γ-globin promoter linked to a neomycin resistance gene. In the positive control plasmid, cHS4 sequences separated the HS2 enhancer from the γ-globin promoterneomycin cassette. Plasmids were co-transfected with a neomycin resistance gene into K562 cells, plated in semisolid medium to allow growth of individual clones, and cultured under G418
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Quantitative chromatin immunoprecipitation (ChIP) assay. Anti-CTCF (07-729)
antibody was obtained from Upstate Biotechnology (Lake Placid, NY). Anti-USF1 (H-86, sc-8983) and USF2 (C-20, sc-862) antibodies were obtained from Santa Cruz Biotechnology (Santa Cruz, CA). ChIP analyses were performed as described. 18 After elution and extraction, immunoprecipitated DNA was analyzed by quantitative real-time PCR (iCycler, BioRad) using primers shown in Supplemental Table 1 . Samples from at least 3 independent immunoprecipitations were analyzed each at least in triplicate as described. 18 The amount of product was determined relative to a standard curve of input chromatin. Amplification of a single product was confirmed by dissociation curve analysis and agarose gel electrophoresis with ethidium bromide staining. Parallel controls for each experiment included samples of no chromatin, no antibody, and nonimmune rabbit IgG. Positive controls for USF and CTCF were also performed.
29-31
Electrophoretic mobility shift assays (EMSA). Nuclear extracts were prepared and binding reactions carried out as described. 17 Competitor oligonucleotides (Supplemental Table   2 ) were added at molar excesses of 100-fold. USF1 and USF2 antibodies used in EMSA were the same as those used in ChIP.
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Results
Transgenic mice express a minimal α-spectrin promoter-exon 1'-intron-1'/
A γ-globin transgene in reticulocytes. In previous transgenic mouse studies, the human α-spectrin gene promoter directed expression of a linked A γ-globin reporter gene only in early stages of erythroid development, with no expression in reticulocytes of lines transmitting the ASp/γ transgene (Supplemental Table 3 ). These results indicated that elements outside the minimal α-spectrin gene promoter are required for expression in adult erythroid cells. 17 Our previous studies Figure 3 , Table 1 , and Supplemental Table 3 Table 4 ).
Three transgenic lines expressing the ASpEx1IVS1/ A γ transgene in reticulocytes were chosen for further analyses of expression in various tissues. In these 3 lines, RNase protection analysis of γ-globin mRNA levels was performed on RNA extracted from 10 different tissues after systemic perfusion with saline immediately prior to sacrificing and tissue harvest. RNase protection did not detect γ-globin mRNA in kidney, brain, heart, liver, lung, or skeletal muscle.
Expression was detected in the hematopoietic tissues, spleen, bone marrow, and thymus (Supplemental Table 5 ).
Splicing of intron 1' is not required for expression of the α-spectrin promoter-exon 1'-intron-1'/
A γ-globin transgene in reticulocytes. The 183-bp region encodes exon 1' and an alternately spliced intron 1' (Figure 1A ), which is excised in ~50% of α-spectrin mRNA Table 3 ).
Reverse-transcription polymerase chain reaction of random-primed reticulocyte mRNA isolated For (Table 1 and Supplemental Table 3 ). The other two lines transmitting the ASpIVS1/γ transgene were silenced and did not express A γ-globin mRNA. Two of 7 transgenic lines with ASpEx1/γ transgene expressed A γ-globin mRNA at low levels, whereas no expression was detected in the other 5 lines, similar to the minimal α-spectrin promoter alone (Table 1 and Supplemental Table   3 ). These data confirm our previous studies that both exon 1' and intron 1' together in their
proper genomic orientation relative to the α-spectrin minimal promoter are required for reporter gene expression in vivo. The other activity of insulator elements is the ability to act as an enhancer blocker when placed between an enhancer and a promoter. 27 To determine whether exon 1' and intron 1' of the α-spectrin gene conferred this activity, these sequences were studied in a well-defined enhancer blocking assay. The α-spectrin sequences or cHS4 (positive control) were used to separate the mouse β-globin HS2 enhancer 28 from a γ-globin promoter linked to a neomycin only.
For personal use at PENN STATE UNIVERSITY on February 23, 2013. bloodjournal.hematologylibrary.org From resistance gene. Plasmids were co-transfected with a neomycin resistance gene into K562 cells and cultured under G418 selection ( Figure 5B ). In the absence of an enhancer blocker (negative control), the HS2 enhancer promoted the growth of numerous G418-resistant colonies. The cHS4 element blocked this activity, as shown previously. 51 None of the α-spectrin fragments could block the effects of mouse β-globin HS2 enhancer elements in this assay ( Figure 5B ).
These data indicate that neither exon 1' not intron 1' have enhancer blocking activity in erythroid cells.
USF but not CTCF proteins occupy the exon 1'-intron 1' region. Previous study of
histone modifications using a chromatin immunoprecipitation (ChIP) assay demonstrated that the core histones H3 and H4 were hyperacetylated in the 183bp region of the α-spectrin gene in erythroid cells, a finding associated with insulator elements conferring barrier function, but not enhancer blocking activity. 48, [52] [53] [54] The region of the cHS4 insulator that functions as a barrier element binds the upstream stimulatory factor (USF) proteins, thought to be necessary for recruitment of histone modifications associated with active chromatin and, by inference, barrier activity. 19, 20, 50 In contrast, vertebrate insulator elements that exhibit enhancer-blocking activity have been shown to bind the 11-zinc finger protein CTCF. 27, 49 USF1 and USF2 are basic helixloop-helix proteins involved in regulation of many hematopoietic genes including HoxB4, β-globin, and glycophorin. 50, [55] [56] [57] We performed ChIP analyses of this region in native K562 chromatin using anti-USF and anti-CTCF antibodies. In K562 cell chromatin, both USF1 and USF2 occupied the 183bp region of the α-spectrin gene ( Figure 6 ). USF1 and USF2 occupancy was found in the positive control, the HS2 region of the β-globin gene locus control region, 29 but not in either of two negative controls, a region of the cerebellar-specific GABRA6 gene, and an unrelated region of the α- Table 2 ) and used in EMSA with K562 cell nuclear extracts. None of the α-spectrin probes yielded a complex on EMSA that migrated at the same location as a complex obtained with the control USF probe and only the control USF probe yielded a complex that was shifted by both USF-1 and USF-2 antiserum (Data not shown). These data indicate that USF proteins interact with other DNA-binding proteins at this site in the α-spectrin gene or are brought to the α-spectrin exon 1' region from a distance, e.g. by formation of a chromatin loop.
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Discussion
The major erythrocyte membrane protein genes, including α-spectrin, β-spectrin, ankyrin, and band 3, share the common feature of utilizing alternate first exons and likely alternate promoters to direct tissue-specific isoform expression. 17, 21, 51, [58] [59] [60] In erythroid cells, all four genes employ GATA-1 dependent, tissue-specific promoters to direct expression of their respective transcripts. In contrast to the other promoters, which direct high levels of expression at all stages of erythroid development, the core α-spectrin gene promoter directs low levels of expression, and then only in the early stages of erythroid development. 17 This observation is surprising, as previous studies have demonstrated that the α-spectrin gene is expressed at high levels in erythroid cells and that expression is controlled at the transcriptional level. [3] [4] [5] [6] The data in this report indicate that a region downstream of the core α-spectrin gene promoter is required for expression in adult erythroid cells (reticulocytes), and, based on the low levels of The spectrin family of genes, including α-spectrin, β-spectrin, and dystrophin, serve as excellent models of complex gene loci structure and function. These loci encode multiple tissue, developmental, and stage-specific isoforms, arising from alternative splicing, alternate polyadenylation, and usage of alternate promoters. 1, 61 Because of the great diversity and complexity of the spectrin family of genes, it is expected that insulator elements with barrier element and/or enhancer blocker activity participate in their regulation. Such activity could participate in the regulation of the heterogeneous isoforms of α-spectrin found in spleen, heart, and reticulocytes. 62 only.
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The mechanisms controlling barrier element structure and function in vertebrates are poorly understood. Studies of the cHS4 barrier element have shown that the transcription factors USF1 and USF2 recruit histone methyltransferase activity, histone acetyltransferase and ATPdependent nucleosome remodeling complexes, 19, 20 supporting the hypothesis that recruitment of enzymes associated with activating histone modifications blocks the mechanism(s) that lead to spreading of gene-silencing associated chromatin alterations into regions of active chromatin. 19, 52, 54, 63 Transgenic studies in both Drosophila and mice have used barrier elements to flank reporter genes to prevent gene silencing and reduce position effect variegation. [64] [65] [66] [67] Barrier elements are found flanking genes or gene clusters or, as in the case of α-spectrin, tightly associated with gene promoters. [68] [69] [70] [71] Much of the data available on barrier element structure and function has come from model organisms or study of the chicken, mouse, or human β-globin gene loci. 70, 72, 73 The barrier element in α-spectrin is the first barrier element described in an erythrocyte membrane protein gene and suggests that other membrane gene loci will require barrier elements to maintain the proper chromatin configuration for expression in erythroid cells as well.
Our previous studies of the 183bp region of the α-spectrin gene demonstrated characteristics associated with barrier elements, including the inability of exon 1' to act as an enhancer in transfection assays, 39 presence of a broad DNase I hypersensitive site indicating a nucleosome-free region, and histone H3 and H4 hyperacetylation. 48, 54, 74 The barrier function contributed by exon 1' accounts for the nearly position-independent, uniform expression of the transgene, an activity confirmed in the gene silencing/position effect variegation barrier assay.
Barrier elements mark the boundary between euchromatin and heterochromatin and, although they do not directly affect the level of expression of a given gene, they are thought to be only.
For personal use at PENN STATE UNIVERSITY on February 23, 2013. bloodjournal.hematologylibrary.org From responsible for preventing the spread of heterochromatin into the gene thereby maintaining the open chromatin structure needed for optimal expression. 75 Occupancy of the region of the chicken β-globin HS4 and α-spectrin 183bp regions with barrier element activity by USF proteins suggests that USF binding is a mechanism also utilized by mammalian barriers, but, as suggested by our studies, not necessarily via DNA binding.
We propose a model of α-spectrin gene regulation that includes exon 1' engaging several proteins, some as yet unknown, including USF and GATA-1 factors, which recruit proteins that provide chromatin modifications to protect the locus from encroachment of heterochromatin into the α-spectrin gene and direct erythroid-specific expression. It is possible that another barrier 5' or 3' of this region participates in protection of euchromatin from the encroachment of heterochromatin into this region in erythroid cells.
Studies of patients with α-spectrin linked hereditary hemolytic anemia have shown that erythroid cells of many patients exhibit decreased α-spectrin mRNA levels and diminished α-spectrin synthesis leading to abnormal, spectrin-deficient erythrocytes. 7, [13] [14] [15] The precise genetic basis(es) of decreased spectrin mRNA accumulation in these cases is not known, even after mutation screening of the minimal promoter and 52 coding region exons of the α-spectrin gene. 16 Thus it is critical to identify cis-elements in the α-spectrin gene outside the coding region as potential sites of mutation in these patients. This region of the α-spectrin gene is an excellent candidate region for mutations associated with decreased α-spectrin gene expression in patients with spectrin-linked hemolytic anemia. The single peaks observed represents uniform expression of human γ-globin in these cells, whereas a bimodal peak represents nonuniform or variegated expression. 23 Representative transgenic lines are shown, with the letters corresponding to Supplemental Table 3 . Abbreviations are: HS2: Hypersensitive site 2 from the mouse β-globin cluster locus control region; EGFP: the coding sequence for the enhanced Green Fluorescent Protein gene; cHS4:
Hypersensitive site 4 from the chicken β-globin cluster locus control region; ASp: α-spectrin;
Asterisks denote mutation of the exon 1' GATA site that disrupts GATA binding to DNA. B. 
